Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions on site

Valuation: Edwards Lifesciences Corporation

Capitalization 41.4B 39.32B 36.57B 32.56B 58.27B 3,508B 64.33B 453B 168B 1,439B 155B 152B 6,217B P/E ratio 2024 *
30.4x
P/E ratio 2025 * 28.1x
Enterprise value 37.98B 36.06B 33.54B 29.87B 53.44B 3,217B 59B 415B 154B 1,320B 143B 140B 5,702B EV / Sales 2024 *
6.51x
EV / Sales 2025 * 6.4x
Free-Float
89.32%
Yield 2024 *
-
Yield 2025 * -
More valuation ratios * Estimated data
Dynamic Chart

Last Transcript: Edwards Lifesciences Corporation

1 day+5.70%
1 week+2.96%
Current month+3.99%
1 month+11.63%
3 months+7.65%
6 months-15.11%
Current year-2.69%
More quotes
1 week
69.35
Extreme 69.35
74.68
1 month
64.89
Extreme 64.89
74.68
Current year
58.93
Extreme 58.93
96.12
1 year
58.93
Extreme 58.93
96.12
3 years
58.93
Extreme 58.93
131.73
5 years
51.51
Extreme 51.5067
131.73
10 years
20.46
Extreme 20.4583
131.73
More quotes
Director TitleAgeSince
Chief Executive Officer 56 2023-05-10
Director of Finance/CFO 57 2013-12-31
Chief Tech/Sci/R&D Officer - 2019-01-31
Manager TitleAgeSince
Chairman 67 2024-05-06
Director/Board Member 60 2015-02-09
Director/Board Member 56 2023-05-10
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+5.70%+2.96%+7.26%-33.73%41.4B
-1.04%+1.38%+6.77%-15.01%204B
+1.52%+2.12%+76.36%+69.86%193B
-1.91%-1.08%+6.36%-23.02%174B
+0.41%+0.10%+65.86%+123.19%133B
+0.12%+1.85%-2.63%-18.85%60.83B
-0.44%-2.63%-10.53%-26.47%43.28B
+0.66%+1.49%+8.78%-7.44%39.72B
+0.53%+0.01%+19.66% - 37.72B
-0.43%-1.40%+52.19%-5.56%36.23B
Average +0.40%+0.74%+23.01%+7.00% 96.39B
Weighted average by Cap. -0.03%+1.29%+29.75%+20.14%
See all sector performances

Financials

2024 *2025 *
Net sales 5.83B 5.54B 5.15B 4.59B 8.21B 494B 9.06B 63.76B 23.7B 203B 21.91B 21.43B 876B 5.92B 5.62B 5.23B 4.66B 8.33B 502B 9.2B 64.72B 24.05B 206B 22.24B 21.75B 889B
Net income 1.39B 1.32B 1.23B 1.09B 1.95B 118B 2.16B 15.16B 5.64B 48.21B 5.21B 5.1B 208B 1.48B 1.41B 1.31B 1.17B 2.09B 126B 2.31B 16.22B 6.03B 51.58B 5.58B 5.45B 223B
Net Debt -3.43B -3.25B -3.03B -2.7B -4.82B -290B -5.32B -37.45B -13.92B -119B -12.87B -12.59B -515B -3.51B -3.34B -3.1B -2.76B -4.94B -298B -5.46B -38.41B -14.27B -122B -13.2B -12.91B -528B
More financial data * Estimated data
Logo Edwards Lifesciences Corporation
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (67.9%); - hemodynamic monitoring systems (15.5%); - other (16.6%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Employees
19,800
Calendar
More about the company
Date Price Change Volume
24-12-04 74.20 $ +5.70% 6,631,471
24-12-03 70.20 $ -0.47% 5,808,909
24-12-02 70.53 $ -1.15% 6,509,833
24-11-29 71.35 $ -1.00% 2,125,966
24-11-27 72.07 $ +0.73% 2,753,319

Delayed Quote Nyse, December 04, 2024 at 04:00 pm EST

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
B+
surperformance-ratings-light-chart EDWARDS-LIFESCIENCES-CORPMore Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
70.20USD
Average target price
76.81USD
Spread / Average Target
+9.41%
Consensus

Quarterly revenue - Rate of surprise

Exceptional Extension | BLACK FRIDAY -40% : Unlock Tomorrow's Top Investments with Our Exclusive Subscriber-Only Tools!
d
:
:
BENEFIT NOW